10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG) is a Healthcare stock tracked by StreetAlpha. TXG reports earnings on Thu, Nov 5, 2026. Analyst consensus is Hold, based on the latest ratings from 11 firms (4 buy, 7 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in TXG, 100% of them bullish and 0% bearish. In the past 30 days there were 7 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 13 | TD Cowen | Maintained | Hold | — |
| Oct 13 | Morgan Stanley | Target raised | Hold | — |
| Oct 12 | Canaccord Genuity | Target raised | Buy | — |
| Oct 7 | Barclays | Target raised | Buy | — |
| Sep 29 | Leerink Partners | Target raised | Hold | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TXG is in one of them and how their past TXG trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TXG in an article yet. Here's the latest on the wider market.